0001474064-11-000058.txt : 20111110
0001474064-11-000058.hdr.sgml : 20111110
20111110115330
ACCESSION NUMBER: 0001474064-11-000058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111109
FILED AS OF DATE: 20111110
DATE AS OF CHANGE: 20111110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BESHAR LUKE M
CENTRAL INDEX KEY: 0001192128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 111193945
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0304
4
2011-11-09
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001192128
BESHAR LUKE M
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
SVP & CFO
Common Stock
2011-11-09
4
P
0
20000
5.36
A
22639
D
Represents the purchase of 20,000 shares in 14 separate transactions, ranging from $5.32 to $5.37 per share, resulting in a weighted average purchase price per share of $5.3572. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range.
Includes 2,639 shares of stock obtained through the Issuer's Employee Stock Purchase Plan.
/s/ Luke Beshar, by Edward Stratemeier as attorney-in-fact
2011-11-10